Law Enforcement and Pain Management - Webinar By MentorHealth February 12, 2013

Overview: Class participants will familiarize themselves with the federal laws and regulations enforced by DEA pertaining to Schedules II though V controlled substances that are dispensed, or prescribed by a physician as part of a pain treatment plan. Also they will be familiarized with the necessary documentation that should be noted in the patient chart and step to prevent diversion of the dispensed or prescribed drugs.

Why should you attend: As a pain management clinic or physician treating pain, you are required by federal and state laws and regulations to take many steps in order to be assured that the controlled substance you dispensed or prescribed are done with a legitimate medical purpose and are being properly used by the patient. This training will cover steps that will assist you in order to comply with these laws and regulations. The topics are focused on the patient-doctor relationship and the necessary information that is need in a patient chart that may result in a prescription for pain. The training will also provide you with a better understanding of DEA and their record keeping and security requirements.

Areas Covered in the Session:
Describe the types of actions that can be imposed by a federal prosecutor's office on a pain management clinic or a physician treating pain. This includes the type of fines that can be imposed through a criminal or civil action utilizing the federal laws and regulations pertaining to the administering, dispensing, and prescribing of controlled substances as part of a pain management treatment plan.
Identify the steps taken by the DEA in enforcing federal laws and regulations through their Office of Diversion Control who is responsible for all investigation and regulatory actions for Schedules II through V controlled substance especially those dispensed or prescribed as part of a pain management treatment plan.
Discuss the importance of a good patient chart that contains all documentation beginning when the patient was initially accepted as a patient to the most recent visit to the clinic or seen by the physician. This includes the patient agreement, the treatment plan, and any controlled substance administered, dispensed or prescribed for the patient.
Review all the requirements pertaining to administering, dispensing and prescribing of controlled substance prescription by a physician as part of a pain management treatment plan. The subjects covered will also include electronic prescriptions, the DEA regulation pertaining to a 90-day supply of a Schedule II drug, and prescriptions written for opioid dependency patients.

Who Will Benefit: All pain management clinics or physicians treating a patient with controlled substances as part of a pain management treatment plans.
Carlos M. Aquino brings 36 years of experience of handling illicit and pharmaceutical controlled substances and regulated chemicals. His testimonial ability, both in federal and state courts, is proof of his investigative experience and skills. Carlos has 12 years of experience working for Philadelphia DEA Diversion Group, which is responsible for initiating prosecutions of those DEA registrants who violate the federal Controlled Substances Act or DEA regulations pertaining to handling these substances. This has included eight years as a Diversion Investigator and four years as a Group Supervisor. During his time at the DEA, he performed numerous regulatory inspections of manufacturers, distributors, importers/exporters, physicians, researchers, and pharmacies in order to determine their compliance with the federal laws and DEA regulations pertaining to controlled substances in Schedules II through V and regulated chemicals.

In addition to the above, Carlos has over 20 years of experience working for various law enforcement agencies including the Philadelphia Police. Carlos has a BA in Criminal Justice and has taught numerous courses during his time at the DEA.

He is skilled in interpreting the Controlled Substances Act (CSA) and the Code of Federal Regulations (CFR), assisting the pharmaceutical industry with compliance, and preparing and submitting Drug Enforcement Administration (DEA) Forms 41, 104, 106, 222, 236, 486.

For more info please visit the site http://alturl.com/d5xe3